After the Ablation: StimCardio, Wearable Neuromodulation and the Next AF Outcome Gap
Dr. Dereck Mush, MD, MBACatalyst Health Ventures
Venture fund
- Stages
- Series A
- Cheque size
- Based in
- North America
- Focus
- Medical devices
StimCardio's October 29, 2026 financing announcement identifies Catalyst Health Ventures as a participating investor and Joshua Phillips as its managing partner and a StimCardio board member. The secondary source link is the company's financing announcement.
Invests early in healthcare technologies; participated in StimCardio's $30 million Series A.
Notable investments
- StimCardio Medical
Investors at similar stages
- 7wireVentures
Venture fund
- Andreessen Horowitz Bio + Health
Venture fund
- Bessemer Venture Partners
Venture fund
- CommonSpirit Ventures
Health system venture investor
- CVS Health Ventures
Corporate venture
- DCVC
Venture fund
Related on The Signal
Dr. Dereck Mush, MD, MBA
Long-Horizon Agentic Workflows in Medicare: Baba and the Economics of Autonomous Care Coordination
Dr. Dereck Mush, MD, MBA
Inside Even Healthcare's $50M Series B: Connecting Managed Care With Delivery
Dr. Dereck Mush, MD, MBA
The $340M Ambient AI Infrastructure Shift: Why Heidi Is Moving Beyond the Point-Solution Scribe
Dr. Dereck Mush, MD, MBAKeep exploring